Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
暂无分享,去创建一个
H. Falhammar | V. Iotova | F. Ceccato | R. Auchus | G. T’Sjoen | W. Bonfig | F. Baronio | M. Cools | J. Tomlinson | R. Ross | Salma R Ali | J. Bryce | G. Guaragna-Filho | G. Russo | E. Costa | M. Miranda | Beatrice Righi | Eleni Daniel | Tania A. S. S. Bachega | R. Markosyan | M. Stancampiano | S. Ahmed | B. Righi | S. Ahmed | Guilherme Guaragna-Filho | S. Ali
[1] M. Geffner,et al. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia , 2022, Frontiers in Endocrinology.
[2] H. Falhammar,et al. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study , 2021, The Journal of clinical endocrinology and metabolism.
[3] P. White,et al. Congenital adrenal hyperplasia - current insights in pathophysiology, diagnostics and management. , 2021, Endocrine reviews.
[4] Jay R. Desai,et al. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. , 2021, The Journal of clinical endocrinology and metabolism.
[5] O. Hiort,et al. Introduction to Endo-ERN–scope and mission , 2021, Endocrine.
[6] H. Falhammar,et al. Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia - a population-based cohort study. , 2020, The Journal of clinical endocrinology and metabolism.
[7] H. Falhammar,et al. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis , 2020, Frontiers in Endocrinology.
[8] M. Bidlingmaier,et al. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[9] S. F. Ahmed,et al. The Role of International Databases in Understanding the Aetiology and Consequences of Differences/Disorders of Sex Development , 2019, International journal of molecular sciences.
[10] B. Okopień,et al. The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study , 2019, Pharmacological reports : PR.
[11] M. Murad,et al. Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis , 2018, The Journal of clinical endocrinology and metabolism.
[12] M. Murad,et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. , 2018, The Journal of clinical endocrinology and metabolism.
[13] R. Herings,et al. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study. , 2017, Clinical therapeutics.
[14] P. Lichtenstein,et al. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study , 2015, Psychoneuroendocrinology.
[15] Jacques Young,et al. Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey. , 2015, The Journal of clinical endocrinology and metabolism.
[16] D. Merke,et al. Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency , 2015, Clinical endocrinology.
[17] A. Lenzi,et al. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia. , 2015, The Journal of clinical endocrinology and metabolism.
[18] R. Ross. CaHASE: a Specialist Society Led Academic Collaboration to improve the management of CAH , 2014, Clinical endocrinology.
[19] B. Okopień,et al. The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. , 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[20] B. Walker,et al. Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE). , 2014, The Journal of clinical endocrinology and metabolism.
[21] P. Lichtenstein,et al. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.
[22] B. Walker,et al. Treatment and health outcomes in adults with congenital adrenal hyperplasia , 2014, Nature Reviews Endocrinology.
[23] B. Okopień,et al. The Effect of Simvastatin Treatment on Plasma Steroid Levels in Females with Non-classic Congenital Adrenal Hyperplasia , 2013, Experimental and Clinical Endocrinology & Diabetes (Barth).
[24] M. Nishitani,et al. Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. , 2012, The Journal of clinical endocrinology and metabolism.
[25] H. Falhammar,et al. Clinical outcomes in the management of congenital adrenal hyperplasia , 2012, Endocrine.
[26] F. Sweep,et al. Adult Patients with Congenital Adrenal Hyperplasia Have Elevated Blood Pressure but Otherwise a Normal Cardiovascular Risk Profile , 2011, PloS one.
[27] J. Connell,et al. Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients , 2010, The Journal of clinical endocrinology and metabolism.
[28] H. Falhammar,et al. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.
[29] C. Scaroni,et al. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.
[30] H. Falhammar,et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2007, The Journal of clinical endocrinology and metabolism.